Correspondence 0001104659-24-069368 from GridAI Technologies Corp. (GRDX)
GridAI Technologies Corp.
Date: June 7, 2024 · CIK: 0001604191 · Accession: 0001104659-24-069368
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-279896
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Attention: Jason Drory Re: Entero Therapeutics, Inc. (the “Company”) Registration Statement on Form S-3 Filed on May 31, 2024 File No. 333-279896
Dear Mr. Drory:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 5:00 p.m. ET on June 10, 2024, or as soon as thereafter practicable.
Please call Jessica Yuan of Ellenoff Grossman & Schole LLP at 212-370-1300 to confirm the effectiveness of the Registration Statement or with any questions.
Very truly yours,
/s/ Sarah Romano
Show Raw Text
CORRESP
1
filename1.htm
Entero Therapeutics, Inc.
777 Yamato Road, Suite 502
Boca Raton, Florida 33431
June 7, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jason Drory
Re:
Entero Therapeutics, Inc. (the “Company”)
Registration Statement on Form S-3
Filed on May 31, 2024
File No. 333-279896
Dear Mr. Drory:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended, the Company hereby requests acceleration of effectiveness of the above referenced Registration
Statement so that it will become effective at 5:00 p.m. ET on June 10, 2024, or as soon as thereafter practicable.
Please call Jessica Yuan
of Ellenoff Grossman & Schole LLP at 212-370-1300 to confirm the effectiveness of the Registration Statement or with any questions.
Very truly yours,
/s/ Sarah Romano
Sarah Romano
Chief Financial Officer
cc:
Ellenoff Grossman & Schole LLP